Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.

OBJECT The goal of this study was to determine whether adenoviral vector-mediated expression of human wildtype p53 can enhance the radiosensitivity of malignant glioma cells that express native wild-type p53. The p53 gene is thought to function abnormally in the majority of malignant gliomas, although it has been demonstrated to be mutated in only approximately 30%. This has led to studies in which adenoviral transduction with wild-type human p53 has been investigated in an attempt to slow tumor cell growth. Recent studies suggest that reconstitution of wild-type p53 can render cells more susceptible to radiation-mediated death, primarily by p53-mediated apoptosis. METHODS Rat RT2 glioma cells were analyzed for native p53 status by reverse transcriptase-polymerase chain reaction and sequence analysis and for p53 expression by Western blot analysis. Clonogenic survival and the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling assay were used to characterize RT2 cell radiosensitivity and apoptosis, respectively, with and without prior transduction with p53-containing and control adenoviral vectors. Animal survival length was monitored after intracerebral implantation with transduced and nontransduced RT2 cells, with and without cranial radiation. The RT2 cells were demonstrated to express native rat wild-type p53 and to markedly overexpress human p53 following adenoviral p53 transduction. The combination of p53 transduction followed by radiation resulted in marked decreases in RT2 cell survival and increases in apoptosis at radiation doses from 2 to 6 Gy. Animals receiving cranial radiation after intracerebral implantation with RT2 cells previously transduced with p53 survived significantly longer than control animals (p<0.01). CONCLUSIONS The ability to enhance the radiosensitivity of malignant glioma cells that express wild-type p53 by using adenoviral transduction to induce overexpression of p53 offers hope for this approach as a therapeutic strategy, not only in human gliomas that express mutant p53, but also in those that express wild-type p53.

[1]  Robert E. Gentry,et al.  Immunobiology of primary intracranial tumors. , 1977, Journal of neurosurgery.

[2]  Z. Hao,et al.  p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy , 1997, Oncogene.

[3]  W. Yung,et al.  Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene. , 1998, Journal of neurosurgery.

[4]  T. Mikkelsen,et al.  Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.

[5]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[6]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[7]  D. Louis.  The p53 Gene and Protein in Human Brain Tumors , 1994, Journal of neuropathology and experimental neurology.

[8]  W. Yung,et al.  Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. , 1996, Cancer research.

[9]  Erwin G. Van Meir,et al.  Analysis of the p53 gene and its expression in human glioblastoma cells. , 1994, Cancer research.

[10]  S. Leenstra,et al.  Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. , 1992, Cancer research.

[11]  J. Bruner,et al.  Correlation of p53 immunoreactivity and sequencing in patients with glioma , 1996, Molecular carcinogenesis.

[12]  A. Giaccia,et al.  Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. , 1997, Cancer research.

[13]  Douglas C. Miller,et al.  A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme , 1993, Brain pathology.

[14]  H. Sussman,et al.  Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy. , 1997, Archives of otolaryngology--head & neck surgery.

[15]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[16]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[17]  D. Miller,et al.  High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. , 1994, Oncogene.

[18]  J. Bruner,et al.  Immunocytochemical detection of p53 in human gliomas. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[19]  V. Tse,et al.  Functional expression of human p21(WAF1/CIP1) gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity. , 1997, Biochemical and biophysical research communications.

[20]  J. Whitsett,et al.  Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. , 1994, Human gene therapy.